Bharat Immunologicals (India) Risk Analysis

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 25.05  1.70  6.36%

Macroaxis considers Bharat Immunologicals to be unknown risk. Bharat Immunologicals secures Sharpe Ratio (or Efficiency) of -0.1253 which signifies that Bharat Immunologicals had -0.1253% of return per unit of standard deviation over the last 1 month. Macroaxis philosophy in foreseeing risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Bharat Immunologicals Biologicals Corp Ltd exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Bharat Immunologicals Mean Deviation of 2.66 and Risk Adjusted Performance of 0.74 to double-check risk estimate we provide.
 Time Horizon     30 Days    Login   to change

Bharat Immunologicals Market Sensitivity

As returns on market increase, Bharat Immunologicals returns are expected to increase less than the market. However during bear market, the loss on holding Bharat Immunologicals will be expected to be smaller as well.
One Month Beta |Analyze Bharat Immunologicals Demand Trend
Check current 30 days Bharat Immunologicals correlation with market (DOW)
β = 0.1481
Bharat Immunologicals Small BetaBharat Immunologicals Beta Legend

Bharat Immunologicals Technical Analysis

Transformation
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Projected Return Density Against Market

Assuming 30 trading days horizon, Bharat Immunologicals has beta of 0.1481 . This suggests as returns on market go up, Bharat Immunologicals average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Bharat Immunologicals Biologicals Corp Ltd will be expected to be much smaller as well. Additionally, Bharat Immunologicals Biologicals Corp Ltd has a negative alpha implying that the risk taken by holding this equity is not justified. The company is significantly underperforming DOW
 Predicted Return Density 
      Returns 
Assuming 30 trading days horizon, the coefficient of variation of Bharat Immunologicals is -797.84. The daily returns are destributed with a variance of 11.98 and standard deviation of 3.46. The mean deviation of Bharat Immunologicals Biologicals Corp Ltd is currently at 2.73. For similar time horizon, the selected benchmark (DOW) has volatility of 1.75
α
Alpha over DOW
=1.34
β
Beta against DOW=0.15
σ
Overall volatility
=3.46
Ir
Information ratio =0.38

Actual Return Volatility

Bharat Immunologicals Biologicals Corp Ltd accepts 3.4614% volatility on return distribution over the 30 days horizon. DOW inherits 1.7524% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 
      Timeline 

Market Risk Breakdown

Bharat Immunologicals Volatility Factors

30 Days Market Risk

Unknown risk

Chance of Distress in 24 months

Unknown Distress

30 Days Economic Sensitivity

Unaffected

Largest Trends

Bharat Immunologicals Largest Period Trend

Investment Outlook

Bharat Immunologicals Investment Opportunity
Bharat Immunologicals Biologicals Corp Ltd has a volatility of 3.46 and is 1.98 times more volatile than DOW. 32% of all equities and portfolios are less risky than Bharat Immunologicals. Compared to the overall equity markets, volatility of historical daily returns of Bharat Immunologicals Biologicals Corp Ltd is lower than 32 (%) of all global equities and portfolios over the last 30 days. Use Bharat Immunologicals Biologicals Corp Ltd to protect against small markets fluctuations. The stock experiences very speculative upward sentiment.. Check odds of Bharat Immunologicals to be traded at 23.8 in 30 days. As returns on market increase, Bharat Immunologicals returns are expected to increase less than the market. However during bear market, the loss on holding Bharat Immunologicals will be expected to be smaller as well.

Bharat Immunologicals correlation with market

Significant diversification
Overlapping area represents the amount of risk that can be diversified away by holding Bharat Immunologicals Biologic and equity matching DJI index in the same portfolio.

Volatility Indicators

Bharat Immunologicals Current Risk Indicators